Proposed Data Collection Submitted for Public Comment and Recommendations, 52577-52579 [2022-18444]
Download as PDF
<![CDATA[
52577
Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices
respondents from 150 to 500 per callback investigation.
Based on these revisions, the total
number of annual respondents
requested is 1,500, which is an increase
of 1,200 over the 300 respondents
previously approved. The annual time
burden requested is 250 hours, which is
an increase of 50 hours over the 200
hours previously approved. There is no
cost to the respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Adult Poison Center Callers .............
Adolescent Poison Center Callers ....
Parent or Guardian Poison Center
Callers.
Call-back Questionnaire for Self ......
Call-back Questionnaire for Self ......
Call-back Questionnaire for Proxy ...
1,200
150
150
1
1
1
10/60
10/60
10/60
200
25
25
Total ...........................................
...........................................................
........................
........................
........................
250
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–18443 Filed 8–25–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–1291; Docket No. CDC–2022–
0097]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice with comment period.
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Generic
Information Collection Request for
Cognitive Testing and Pilot Testing for
the National Center for Chronic Disease
Prevention and Health Promotion. The
Generic Clearance is needed to support
methodological studies that improve
information quality and the efficiency of
information collection.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
responses per
respondent
Number of
respondents
Type of respondents
CDC must receive written
comments on or before October 25,
2022.
DATES:
VerDate Sep<11>2014
16:59 Aug 25, 2022
Jkt 256001
You may submit comments,
identified by Docket No. CDC–2022–
0097 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
ADDRESSES:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Generic Information Collection
Request (ICR) for Cognitive Testing and
Pilot Testing for the National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP) (OMB Control
No. 0921–1291, Exp. 03/31/2023)—
Extension—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC’s National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP) plans has
established a Generic Clearance (OMB
Control No. 0920–1291) to support
information collection for cognitive
testing and pilot testing activities.
Information collections that support the
E:\FR\FM\26AUN1.SGM
26AUN1
52578
Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices
Behavioral Risk Factor Surveillance
System (BRFSS) and other NCCDPHP
programs are expected to be the major
focus of activity under this Generic
mechanism. Additional information
collections may also be considered for
submission through this Generic
Clearance if they are relevant to BRFSS
and NCCDPHP programs or
collaborations.
Cognitive testing and pilot testing are
methodological procedures conducted
to prepare for a large scale or key
information collection. Cognitive and
pilot testing activities are designed to
improve information quality and the
efficiency of information collection by
addressing issues such as the use of new
or existing survey questions, question
formatting, survey protocols, data
collection software systems and other
related processes.
Cognitive testing is a technique used
to clarify the meaning of survey
questions and/or the response options
for questions and contributes to the
understanding of the validity and
reliability of questions used for a variety
of public health purposes. Cognitive
testing is conducted early in the process
of considering questions for use in a
survey or other information collection
activity. This type of testing is usually
conducted in a controlled setting, and
respondents participate in a discussion
or interview with a trained interviewer
and may respond individually or as
members of focus groups.
recruitment process to assist in the
selection of respondents. Respondents
may be recruited to take part in testing
through online, mobile devices,
mailings, or newspaper advertisements.
If the participants are not recruited to be
present at a physical location, they may
be called and recruited by telephone.
Cognitive and pilot testing are
efficient means of identifying problems
with questions and procedures prior to
implementation of data collection.
Thus, they are cost effective approaches
to providing evidence on survey
questionnaire performance. A
consequence of cognitive and pilot
testing is to maintain high levels of
participation in the information
collection process itself.
Initial response and burden estimates
are based on anticipated information
collection needs for the BRFSS, with an
additional allocation for a variety of
NCCDPHP programs and collaborators.
Each information collection activity
conducted through this Generic
Clearance will be submitted to OMB for
approval in a project-specific
information collection request that
describes its purpose and methods.
Participation in cognitive and pilot
testing is voluntary, but respondents
will be encouraged to participate by
explanations of the need for their input
in the introduction of each survey. CDC
requests OMB approval for an estimated
8,950 annual burden hours. There are
no costs to respondents other than their
time.
Questions may undergo cognitive
testing because they have not been used
in previous surveys; for example,
questions related to the emergence of a
new public health concern (such as ecigarettes). In addition, testing may be
conducted on previously used questions
to assess their use in a different
information collection mode. Testing
might be conducted to convert questions
developed for a paper survey to an
interview format or an electronic survey
format; or testing might be conducted to
identify issues specific to a
subpopulation or language translation.
Respondents are asked to review
questions and/or surveys to discuss
their impressions of the items under
consideration, the questions, the
response set, individual words within
the question, or the focus of the
questionnaire itself. Incentives may be
offered to respondents who participate
in the in-person phase of cognitive
testing since these activities involve
additional burden and inconvenience.
Pilot testing is used to determine
whether methods or modes of data
collection (such as phone or mail
surveys, in-person interviews or online
data collection) are appropriate and
efficient ways of collecting data. Pilot
testing may include testing of changes
in sampling or contacting potential
respondents.
The majority of participants in
cognitive and pilot testing activities are
expected to be adults >18 years of age.
Information may be collected during the
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hrs)
Total burden
(in hrs)
Form name
General U.S. Population or Selected
Subpopulation.
Screening for cognitive testing .........
2,500
1
15/60
625
Screening for pilot testing ................
Cognitive testing in person ..............
Cognitive testing by phone ..............
Cognitive testing by ABS/mail/web ..
Pilot testing in person ......................
Pilot testing by phone ......................
Pilot testing by ABS/mail/web ..........
2,400
1,500
1,500
600
1,000
3,000
5,000
1
1
1
1
1
1
1
15/60
60/60
45/60
60/60
30/60
30/60
30/60
600
1,500
1,125
600
500
1,500
2,500
...........................................................
........................
........................
........................
8,950
Total ...........................................
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–18444 Filed 8–25–22; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:46 Aug 25, 2022
Jkt 256001
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
E:\FR\FM\26AUN1.SGM
26AUN1
52579
Federal Register / Vol. 87, No. 165 / Friday, August 26, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–0009]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘National
Disease Surveillance Program—I. Case
Reports’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on May 23,
2022, to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
National Disease Surveillance
Program—I. Case Reports (OMB Control
No. 0920–0009, Exp. 08/31/2022)—
Revision—National Center for Emerging
and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Surveillance of the incidence and
distribution of disease has been an
important function of the US Public
Health Service (PHS) since an 1878 Act
of Congress authorized the PHS to
collect morbidity reports. After the
Malaria Control in War Areas Program
had fulfilled its original 1942 objective
of reducing malaria transmission, its
basic tenets were carried forward and
broadened by the formation of the
Communicable Disease Center (CDC) in
1946. CDC was conceived of as a wellequipped, broadly staffed agency used
to translate facts about analysis of
morbidity and mortality statistics on
communicable diseases and through
field investigations. It was soon
recognized that control measures (such
as the DDT spraying for malaria) did not
alleviate the threat of disease
reintroduction. In 1950, the Malaria
Surveillance Program began and in
1952, the National Surveillance Program
started. Both programs were based on
the premise that diseases cannot be
diagnosed, prevented, or controlled
until existing knowledge is expanded
and new ideas developed and
implemented. The original scope of the
National Surveillance Program included
the study of malaria, murine typhus,
smallpox, psittacosis, diphtheria,
leprosy, and sylvatic plague. Over the
years, the mandate of CDC has
broadened in preventive health
activities and the surveillance systems
maintained have expanded. This
program is authorized under the Public
Health Service Act, Section 301 and 306
(42 U.S.C. 241 and 242K).
This ICR covers surveillance activities
for four, rare diseases:
1. Creutzfeldt-Jakob Disease (CJD)
2. Reye Syndrome
3. Kawasaki Syndrome
4. Acute Flaccid Myelitis
CDC requests OMB approval for an
estimated 98 annual burden hours.
There is no cost to respondents other
than their time to participate.
lotter on DSK11XQN23PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Epidemiologist .................................................
Creutzfeldt-Jakob Disease (CJD) ..................
Reye Syndrome .............................................
Kawasaki Syndrome ......................................
Acute Flaccid Myelitis ....................................
10
1
20
100
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–18441 Filed 8–25–22; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:46 Aug 25, 2022
Jkt 256001
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
E:\FR\FM\26AUN1.SGM
26AUN1
Number of
responses per
respondent
2
1
2
4
Average
burden
per response
(in hours)
20/60
20/60
15/60
12/60
]]>Agencies
[Federal Register Volume 87, Number 165 (Friday, August 26, 2022)]
[Notices]
[Pages 52577-52579]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18444]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1291; Docket No. CDC-2022-0097]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled Generic Information Collection Request for Cognitive Testing and
Pilot Testing for the National Center for Chronic Disease Prevention
and Health Promotion. The Generic Clearance is needed to support
methodological studies that improve information quality and the
efficiency of information collection.
DATES: CDC must receive written comments on or before October 25, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0097 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Generic Information Collection Request (ICR) for Cognitive Testing
and Pilot Testing for the National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP) (OMB Control No. 0921-1291,
Exp. 03/31/2023)--Extension--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC's National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP) plans has established a Generic Clearance (OMB
Control No. 0920-1291) to support information collection for cognitive
testing and pilot testing activities. Information collections that
support the
[[Page 52578]]
Behavioral Risk Factor Surveillance System (BRFSS) and other NCCDPHP
programs are expected to be the major focus of activity under this
Generic mechanism. Additional information collections may also be
considered for submission through this Generic Clearance if they are
relevant to BRFSS and NCCDPHP programs or collaborations.
Cognitive testing and pilot testing are methodological procedures
conducted to prepare for a large scale or key information collection.
Cognitive and pilot testing activities are designed to improve
information quality and the efficiency of information collection by
addressing issues such as the use of new or existing survey questions,
question formatting, survey protocols, data collection software systems
and other related processes.
Cognitive testing is a technique used to clarify the meaning of
survey questions and/or the response options for questions and
contributes to the understanding of the validity and reliability of
questions used for a variety of public health purposes. Cognitive
testing is conducted early in the process of considering questions for
use in a survey or other information collection activity. This type of
testing is usually conducted in a controlled setting, and respondents
participate in a discussion or interview with a trained interviewer and
may respond individually or as members of focus groups.
Questions may undergo cognitive testing because they have not been
used in previous surveys; for example, questions related to the
emergence of a new public health concern (such as e-cigarettes). In
addition, testing may be conducted on previously used questions to
assess their use in a different information collection mode. Testing
might be conducted to convert questions developed for a paper survey to
an interview format or an electronic survey format; or testing might be
conducted to identify issues specific to a subpopulation or language
translation. Respondents are asked to review questions and/or surveys
to discuss their impressions of the items under consideration, the
questions, the response set, individual words within the question, or
the focus of the questionnaire itself. Incentives may be offered to
respondents who participate in the in-person phase of cognitive testing
since these activities involve additional burden and inconvenience.
Pilot testing is used to determine whether methods or modes of data
collection (such as phone or mail surveys, in-person interviews or
online data collection) are appropriate and efficient ways of
collecting data. Pilot testing may include testing of changes in
sampling or contacting potential respondents.
The majority of participants in cognitive and pilot testing
activities are expected to be adults >18 years of age. Information may
be collected during the recruitment process to assist in the selection
of respondents. Respondents may be recruited to take part in testing
through online, mobile devices, mailings, or newspaper advertisements.
If the participants are not recruited to be present at a physical
location, they may be called and recruited by telephone.
Cognitive and pilot testing are efficient means of identifying
problems with questions and procedures prior to implementation of data
collection. Thus, they are cost effective approaches to providing
evidence on survey questionnaire performance. A consequence of
cognitive and pilot testing is to maintain high levels of participation
in the information collection process itself.
Initial response and burden estimates are based on anticipated
information collection needs for the BRFSS, with an additional
allocation for a variety of NCCDPHP programs and collaborators. Each
information collection activity conducted through this Generic
Clearance will be submitted to OMB for approval in a project-specific
information collection request that describes its purpose and methods.
Participation in cognitive and pilot testing is voluntary, but
respondents will be encouraged to participate by explanations of the
need for their input in the introduction of each survey. CDC requests
OMB approval for an estimated 8,950 annual burden hours. There are no
costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hrs) (in hrs)
----------------------------------------------------------------------------------------------------------------
General U.S. Population or Screening for 2,500 1 15/60 625
Selected Subpopulation. cognitive
testing.
Screening for 2,400 1 15/60 600
pilot testing.
Cognitive 1,500 1 60/60 1,500
testing in
person.
Cognitive 1,500 1 45/60 1,125
testing by
phone.
Cognitive 600 1 60/60 600
testing by ABS/
mail/web.
Pilot testing in 1,000 1 30/60 500
person.
Pilot testing by 3,000 1 30/60 1,500
phone.
Pilot testing by 5,000 1 30/60 2,500
ABS/mail/web.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 8,950
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-18444 Filed 8-25-22; 8:45 am]
BILLING CODE 4163-18-P
